Literature DB >> 19920219

Simple modeling allows prediction of steady-state glucose disposal rate from early data in hyperinsulinemic glucose clamps.

Pooja Singal1, Ranganath Muniyappa, Robin Chisholm, Gail Hall, Hui Chen, Michael J Quon, Kieren J Mather.   

Abstract

After a constant insulin infusion is initiated, determination of steady-state conditions for glucose infusion rates (GIR) typically requires >or=3 h. The glucose infusion follows a simple time-dependent rise, reaching a plateau at steady state. We hypothesized that nonlinear fitting of abbreviated data sets consisting of only the early portion of the clamp study can provide accurate estimates of steady-state GIR. Data sets from two independent laboratories were used to develop and validate this approach. Accuracy of the predicted steady-state GDR was assessed using regression analysis and Altman-Bland plots, and precision was compared by applying a calibration model. In the development data set (n = 88 glucose clamp studies), fitting the full data set with a simple monoexponential model predicted reference GDR values with good accuracy (difference between the 2 methods -0.37 mg x kg(-1) x min(-1)) and precision [root mean square error (RMSE) = 1.11], validating the modeling procedure. Fitting data from the first 180 or 120 min predicted final GDRs with comparable accuracy but with progressively reduced precision [fitGDR-180 RMSE = 1.27 (P = NS vs. fitGDR-full); fitGDR-120 RMSE = 1.56 (P < 0.001)]. Similar results were obtained with the validation data set (n = 183 glucose clamp studies), confirming the generalizability of this approach. The modeling approach also derives kinetic parameters that are not available from standard approaches to clamp data analysis. We conclude that fitting a monoexponential curve to abbreviated clamp data produces steady-state GDR values that accurately predict the GDR values obtained from the full data sets, albeit with reduced precision. This approach may help reduce the resources required for undertaking clamp studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920219      PMCID: PMC2822473          DOI: 10.1152/ajpendo.00603.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  27 in total

1.  QUICKI is a useful index of insulin sensitivity in subjects with hypertension.

Authors:  Hui Chen; Gail Sullivan; Lilly Q Yue; Arie Katz; Micheal J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04       Impact factor: 4.310

2.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Authors:  Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Authors:  A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

Review 5.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

6.  Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.

Authors:  A Dunaif; K R Segal; W Futterweit; A Dobrjansky
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

7.  Assessment of hepatic insulin action in obese type 2 diabetic patients.

Authors:  P Staehr; O Hother-Nielsen; K Levin; J J Holst; H Beck-Nielsen
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

8.  Repeatability characteristics of simple indices of insulin resistance: implications for research applications.

Authors:  K J Mather; A E Hunt; H O Steinberg; G Paradisi; G Hook; A Katz; M J Quon; A D Baron
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

9.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

10.  Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.

Authors:  Giancarlo Paradisi; Helmut O Steinberg; Marguerite K Shepard; Ginger Hook; Alain D Baron
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

View more
  4 in total

1.  Assessing the predictive accuracy of oral glucose effectiveness index using a calibration model.

Authors:  Michael Glicksman; Shivraj Grewal; Shrayus Sortur; Brent S Abel; Sungyoung Auh; Trudy R Gaillard; Kwame Osei; Ranganath Muniyappa
Journal:  Endocrine       Date:  2018-11-06       Impact factor: 3.633

2.  [13C]glucose breath testing provides a noninvasive measure of insulin resistance: calibration analyses against clamp studies.

Authors:  Maysa Hussain; Morteza Jangorbhani; Sally Schuette; Robert V Considine; Robin L Chisholm; Kieren J Mather
Journal:  Diabetes Technol Ther       Date:  2013-10-11       Impact factor: 6.118

3.  Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.

Authors:  A A Lteif; R L Chisholm; K Gilbert; R V Considine; K J Mather
Journal:  Diabetes Obes Metab       Date:  2011-11-24       Impact factor: 6.577

4.  Precision and accuracy of hyperglycemic clamps in a multicenter study.

Authors:  Kieren J Mather; Ashley H Tjaden; Adam Hoehn; Kristen J Nadeau; Thomas A Buchanan; Steven E Kahn; Silva A Arslanian; Sonia Caprio; Karen M Atkinson; Melanie Cree-Green; Kristina M Utzschneider; Sharon L Edelstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-03-01       Impact factor: 4.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.